# Fentanyl Buccal Tablet for the Relief of Episodic Breathlessness in Cancer Patients

> **NCT04635852** · PHASE2 · COMPLETED · sponsor: **University of Cologne** · enrollment: 10 (actual)

## Conditions studied

- Cancer
- Dyspnea, Paroxysmal

## Interventions

- **DRUG:** Fentanyl
- **DRUG:** Immediate release morphine

## Key facts

- **NCT ID:** NCT04635852
- **Lead sponsor:** University of Cologne
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2014-11
- **Final completion:** 2014-12
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-11-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04635852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04635852, "Fentanyl Buccal Tablet for the Relief of Episodic Breathlessness in Cancer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04635852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*